A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

NCT02409199 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Gastric Carcinoma

Interventions

DRUG: Docetaxel
DRUG: apatinib

Sponsor

Shanghai Zhongshan Hospital